Shao-Rui Chen Selected Research

iodoresiniferatoxin

1/2019	Endogenous transient receptor potential ankyrin 1 and vanilloid 1 activity potentiates glutamatergic input to spinal lamina I neurons in inflammatory pain.
9/2004	Sensing tissue ischemia: another new function for capsaicin receptors?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shao-Rui Chen Research Topics

Disease

39	Neuralgia (Stump Neuralgia) 12/2022 - 02/2002
29	Pain (Aches) 12/2022 - 09/2002
20	Hyperalgesia 01/2021 - 02/2002
19	Hypersensitivity (Allergy) 01/2022 - 01/2014
8	Chronic Pain 11/2019 - 02/2002
8	Diabetic Neuropathies (Diabetic Neuropathy) 11/2019 - 11/2003
7	Hypertension (High Blood Pressure) 01/2022 - 09/2014
5	Peripheral Nervous System Diseases (PNS Diseases) 05/2019 - 01/2016
5	Neoplasms (Cancer) 01/2019 - 04/2013
5	Cardiomegaly (Heart Hypertrophy) 09/2017 - 03/2012
4	Ischemia 03/2022 - 02/2002
3	Brain Injuries (Brain Injury) 03/2022 - 10/2018
3	Peripheral Nerve Injuries 05/2019 - 09/2012
3	Painful Neuropathy 12/2017 - 08/2014
2	Nervous System Diseases (Neurological Disorders) 01/2021 - 01/2021
2	Postherpetic Neuralgia 01/2021 - 04/2005
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2020 - 10/2018
2	Brain Ischemia (Cerebral Ischemia) 10/2020 - 10/2018
2	Hypertrophy 05/2017 - 01/2013
2	Fibrosis (Cirrhosis) 05/2017 - 01/2014
2	Myasthenia Gravis 12/2014 - 12/2009
2	Spinal Cord Injuries (Spinal Cord Injury) 12/2014 - 12/2009
2	Multiple Sclerosis 12/2014 - 12/2009
2	Inflammation (Inflammations) 04/2013 - 01/2010
2	Myocardial Ischemia (Ischemic Heart Diseases) 09/2004 - 02/2002
1	Autoimmune Diseases (Autoimmune Disease) 12/2022
1	Herpes Zoster 01/2021
1	Brain Infarction 10/2018
1	Infarction (Infarctions) 10/2018

Drug/Important Bio-Agent (IBA)

23	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 08/2009
18	Analgesics (Analgesic Drugs)IBA 01/2020 - 02/2002
10	Opioid Analgesics (Opioids)IBA 01/2019 - 12/2002
9	Gabapentin (Neurontin)FDA LinkGeneric 01/2022 - 04/2005
9	Glutamic Acid (Glutamate)FDA Link 01/2022 - 02/2002
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2011
7	Peptides (Polypeptides)IBA 01/2022 - 10/2018
7	Morphine (MS Contin)FDA LinkGeneric 01/2019 - 06/2002
5	Calcineurin InhibitorsIBA 12/2022 - 04/2013
5	Streptozocin (Streptozotocin)FDA Link 11/2019 - 06/2002
5	Angiotensin IIIBA 01/2019 - 03/2012
5	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 11/2014
5	Small Interfering RNA (siRNA)IBA 12/2018 - 02/2012
4	Tacrolimus (Prograf)FDA LinkGeneric 12/2022 - 04/2013
4	CalcineurinIBA 12/2022 - 04/2013
4	CannabinoidsIBA 01/2022 - 06/2012
4	Memantine (Namenda)FDA Link 01/2021 - 08/2009
4	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2020 - 01/2005
4	Protein Kinase CIBA 01/2019 - 01/2016
4	Opioid Receptors (Opioid Receptor)IBA 01/2019 - 04/2016
4	N-Methylaspartate (NMDA)IBA 10/2017 - 08/2009
4	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 11/2011 - 09/2002
3	AMPA Receptors (AMPA Receptor)IBA 01/2022 - 11/2019
3	resiniferatoxinIBA 01/2021 - 04/2003
3	CalpainIBA 10/2018 - 09/2012
3	Casein Kinase II (Casein Kinase 2)IBA 09/2014 - 05/2014
3	Cholinergic Agents (Cholinergics)IBA 11/2011 - 03/2003
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2022 - 05/2014
2	AnionsIBA 03/2022 - 10/2020
2	CalciumIBA 01/2022 - 11/2019
2	Calcium Channels (Calcium Channel)IBA 01/2021 - 05/2019
2	iodoresiniferatoxinIBA 01/2019 - 09/2004
2	MuscarineIBA 12/2018 - 03/2003
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2017 - 09/2011
2	Atrial Natriuretic Factor (ANF)IBA 09/2017 - 05/2017
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2016 - 09/2012
2	ChloridesIBA 01/2016 - 09/2012
2	4-Aminopyridine (4 Aminopyridine)FDA Link 12/2014 - 12/2009
2	Glycine Receptors (Glycine Receptor)IBA 02/2014 - 06/2012
2	Biomarkers (Surrogate Marker)IBA 01/2014 - 01/2013
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 06/2012 - 09/2010
2	Capsaicin (Zostrix)FDA Link 04/2005 - 04/2003
2	AcidsIBA 01/2005 - 02/2002
2	BradykininIBA 09/2004 - 02/2002
2	Neostigmine (Neostigmine Bromide)IBA 11/2003 - 03/2003
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 11/2003 - 09/2002
2	D-Penicillamine (2,5)- EnkephalinIBA 01/2003 - 12/2002
1	Immunosuppressive Agents (Immunosuppressants)IBA 12/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	1,1-dimethylbutyl-1-deoxy-Delta(9)-THCIBA 01/2022
1	Histone MethyltransferasesIBA 01/2020
1	Pregabalin (Lyrica)FDA Link 01/2019
1	Receptors for Activated C KinaseIBA 01/2019
1	Freund's AdjuvantIBA 01/2019
1	AnkyrinsIBA 01/2019
1	Type 1 Angiotensin ReceptorIBA 01/2019
1	AM-0902IBA 01/2019
1	RE1-silencing transcription factorIBA 12/2018
1	ReninIBA 11/2018
1	AngiotensinsIBA 11/2018
1	Caspase 3 (Caspase-3)IBA 10/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	MethyltransferasesIBA 01/2018
1	RG108IBA 01/2018
1	Arginine (L-Arginine)FDA Link 10/2017

Therapy/Procedure

17	Spinal Injections 01/2022 - 11/2003
6	Drug Therapy (Chemotherapy) 05/2019 - 11/2014
4	Ligation 01/2018 - 02/2002
1	Organ Transplantation 12/2022
1	Intraperitoneal Injections 01/2019
1	Analgesia 01/2019